Cullen/Frost Bankers, Inc. Vericel Corp Transaction History
Cullen/Frost Bankers, Inc.
- $7.21 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
293Shares Held
50.7MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$394 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$170 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$158 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$117 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$109 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.3B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...